News

Not everyone is a fan of exercise, and you've probably heard more than a few jokes from people who say they're "allergic" to ...
A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...
There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...
Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...
Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are ...
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL ...
Jeanetta has been feeling poorly and never knew why until recently.
T-Mobile is continuing its commitment to Louisiana with expansions of its 5G wireless services, more retail stores with local ...
Jasper Therapeutics, Inc.’s JSPR share price has surged by 7.55%, which has investors questioning if this is right time to sell.